Galena Biopharma Inc (GALE)

0.45
0.02 4.20
NASDAQ : Health Care
Prev Close 0.47
Open 0.45
Day Low/High 0.44 / 0.47
52 Wk Low/High 0.28 / 2.49
Volume 4.99M
Avg Volume 8.21M
Exchange NASDAQ
Shares Outstanding 181.84M
Market Cap 83.65M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

2 Big-Volume Stocks to Add to Your Buy List -- Plus 5 Risky Ones to Avoid

2 Big-Volume Stocks to Add to Your Buy List -- Plus 5 Risky Ones to Avoid

Here's a technical look at how to trade some of the most active stocks on the market right now.

Galena Craters on Breast Cancer Vaccine Study Failure

Galena Craters on Breast Cancer Vaccine Study Failure

The inevitable failure of Galena Biopharma's breast cancer vaccine NeuVax was apparent in shoddy clinical data presented four years ago. On Wednesday, the bear call on Galena was proven correct.

First Week of GALE August 19th Options Trading

First Week of GALE August 19th Options Trading

Investors in Galena Biopharma Inc saw new options begin trading this week, for the August 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new August 19th contracts and identified one put and one call contract of particular interest.

Galena (GALE) Stock Soared Today, Breast Cancer Treatment Received 'Fast Track' Designation

Galena (GALE) Stock Soared Today, Breast Cancer Treatment Received 'Fast Track' Designation

Galena (GALE) stock closed sharply higher on Wednesday after its breast cancer treatment received a Fast Track designation from the FDA.

7 Big-Volume Stocks to Trade for Big Gains

7 Big-Volume Stocks to Trade for Big Gains

Here's a technical look at how to trade some of the most active stocks on the market right now.

Why Galena Biopharma (GALE) Stock Is Spiking Today

Why Galena Biopharma (GALE) Stock Is Spiking Today

Galena Biopharma (GALE) stock is up in late-morning trading on Wednesday as its NeuVax drug has received Fast Track designation by the FDA.

Noteworthy Tuesday Option Activity: GALE, ANF, VEEV

Noteworthy Tuesday Option Activity: GALE, ANF, VEEV

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Galena Biopharma Inc , where a total volume of 7,760 contracts has been traded thus far today, a contract volume which is representative of approximately 776,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 50.1% of GALE's average daily trading volume over the past month, of 1.5 million shares.

Commit To Purchase Galena Biopharma At $1, Earn 36.1% Annualized Using Options

Commit To Purchase Galena Biopharma At $1, Earn 36.1% Annualized Using Options

Investors eyeing a purchase of Galena Biopharma Inc shares, but tentative about paying the going market price of $1.65/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $1 strike, which has a bid at the time of this writing of 10 cents.

Biotech Stock Mailbag: Intercept, Acadia, Keryx, Galena

Biotech Stock Mailbag: Intercept, Acadia, Keryx, Galena

TheStreet's Senior Columnist Adam Feuerstein answers reader questions about biotech stock investing.

Here’s Why Galena Biopharma (GALE) Stock is Spiking Today

Here’s Why Galena Biopharma (GALE) Stock is Spiking Today

Galena Biopharma (GALE) stock is rising on Tuesday afternoon as the biopharmaceutical company said its phase 3 clinical trial for its NeuVax vaccine achieved 70th qualifying disease free survival event.

Galena Biopharma Phase 3 PRESENT Clinical Trial With NeuVax™ (nelipepimut-S) Achieves 70th Qualifying Disease Free Survival Event

Galena Biopharma Phase 3 PRESENT Clinical Trial With NeuVax™ (nelipepimut-S) Achieves 70th Qualifying Disease Free Survival Event

Interim analysis results expected by the end of the second quarter

Notable Tuesday Option Activity: GALE, BPI, GMED

Notable Tuesday Option Activity: GALE, BPI, GMED

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Galena Biopharma Inc , where a total of 52,779 contracts have traded so far, representing approximately 5.3 million underlying shares. That amounts to about 437.5% of GALE's average daily trading volume over the past month of 1.2 million shares.

Galena Not Named Target of Federal Criminal Probe Into Painkiller Use

Galena Not Named Target of Federal Criminal Probe Into Painkiller Use

Galena isn't the target of a criminal investigation that has already led to the arrests of two doctors, charged with allegedly running a fraudulent painkiller pill mill and taking kickbacks.